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Abstract
The 16 EphA and EphB receptors represent the largest family of receptor tyrosine kinases, and their interactions with 9
ephrin-A and ephrin-B ligands initiate bidirectional signals controlling many physiological and pathological processes. Most
interactions occur between receptor and ephrins of the same class, and only EphA4 can bind all A and B ephrins. To
understand the structural and dynamic principles that enable Eph receptors to utilize the same jellyroll b-sandwich fold to
bind ephrins, the VAPB-MSP domain, peptides and small molecules, we have used crystallography, NMR and molecular
dynamics (MD) simulations to determine the first structure and dynamics of the EphA5 ligand-binding domain (LBD), which
only binds ephrin-A ligands. Unexpectedly, despite being unbound, the high affinity ephrin-binding pocket of EphA5
resembles that of other Eph receptors bound to ephrins, with a helical conformation over the J–K loop and an open pocket.
The openness of the pocket is further supported by NMR hydrogen/deuterium exchange data and MD simulations.
Additionally, the EphA5 LBD undergoes significant picosecond-nanosecond conformational exchanges over the loops, as
revealed by NMR and MD simulations, but lacks global conformational exchanges on the microsecond-millisecond time
scale. This is markedly different from the EphA4 LBD, which shares 74% sequence identity and 87% homology.
Consequently, the unbound EphA5 LBD appears to comprise an ensemble of open conformations that have only small
variations over the loops and appear ready to bind ephrin-A ligands. These findings show how two proteins with high
sequence homology and structural similarity are still able to achieve distinctive binding specificities through different
dynamics, which may represent a general mechanism whereby the same protein fold can serve for different functions. Our
findings also suggest that a promising strategy to design agonists/antagonists with high affinity and selectivity might be to
target specific dynamic states of the Eph receptor LBDs.
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Introduction
The Eph receptors constitute the largest family of receptor
tyrosine kinases, with 16 members in vertebrates, which can be
activated by 9 ephrin ligands [1–6]. Eph receptors and ephrins are
both anchored onto the plasma membrane, and the interactions
between them initiate bidirectional signals that direct pattern
formation and morphogenetic processes such as axon growth, cell
assembly and migration, and angiogenesis [1–8]. As they function
in both physiology and disease, Eph receptors and ephrins also
represent promising targets for drug design.
Based on their sequence conservation and binding preferences,
Eph receptors and ephrins are subdivided into two classes: A and
B. In general, EphA receptors (EphA1-A10) only interact with
glycosylphosphatidylinositol (GPI)-anchored ephrin-A ligands
(ephrin-A1-A6), while EphB receptors (EphB1-B6) interact with
transmembrane ephrin-B ligands (ephrin-B1-ephrin-B3). Interac-
tions between the Eph receptors and ephrins of the same class are
quite promiscuous but interactions between classes are relatively
rare. EphA4 is the only receptor capable of interacting with all 9
ephrins of both A and B classes [7].
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All Eph receptors share the same modular structure, consisting
of a unique N-terminal globular domain that mediates high-
affinity ephrin binding [8,9], followed by a cysteine-rich linker and
two fibronectin type III repeats in the extracellular region. The
intracellular region is composed of a juxtamembrane segment, a
conserved tyrosine kinase domain, a C-terminal sterile a-domain,
and a PDZ domain-binding motif. The crystal structures of several
Eph receptor ligand-binding domains (LBDs) in the free state or in
complex with ephrins or peptides have been determined [8–21].
The LBDs of both EphA and EphB receptors adopt the same
jellyroll b-sandwich architecture composed of 11 antiparallel b-
strands connected by loops of various lengths. The formation of a
complex between an Eph receptor and an ephrin is characterized
by the insertion of the solvent exposed ephrin G–H loop into an
Eph receptor hydrophobic pocket delimited by a convex sheet of
four b-strands capped by the D–E, G–H and J–K loops. A notable
feature uncovered by the previously determined structures is that
while the jellyroll b-sandwich core is highly similar regardless of
whether an Eph receptor is unbound or in complex with a ligand,
loops such as the D–E, G–H and J–K loops can adopt
dramatically different conformations.
The unique ability of the Eph receptor LBD to use the same
fold to bind ephrins, antagonistic peptides, small molecules
[12,22,23] and the MSP domain of VAPB [24,25] makes them
an attractive model system for deciphering the structural and
dynamic principles governing protein-ligand interactions. Our
understanding of molecular recognition is still incomplete and the
role of protein dynamics in the regulation of binding affinity and
specificity is only beginning to be understood [14,25–36]. We
previously used crystallography, NMR spectroscopy and molecu-
lar dynamics simulations to demonstrate the co-existence of
multiple conformations over the loops of the unbound EphA4
LBD, which can interconvert on the picosecond to nanosecond
(ps-ns) time scale [14]. Moreover, the high-affinity ephrin-binding
pocket of the EphA4 LBD appears to also undergo a significant
conformational transition from a closed to an open state in order
to bind ephrins [14]. This conformational exchange is character-
ized by the chameleon transformation of a short b-sheet in the J–K
loop into helical-like conformations. Molecular dynamics simula-
tions imply that the closed and open conformations are separated
by a relatively large energy barrier and consequently their
interconversion likely occurs on the microsecond to millisecond
(ms-ms) time scale. Therefore, open and closed conformational
states of the EphA4 LBD that can bind diverse ligands already co-
exist despite being unbound, and the introduction of a certain
ligand shifts the equilibrium towards an increase in the confor-
mational state that binds that ligand [14,35]. Consistent with this
scenario, using NMR spectroscopy, we recently found that the
EphA4 LBD undergoes dramatic conformational exchanges not
only in loop regions on ps-ns, but also over the whole molecule on
ms-ms time scales [36].
To assess whether protein dynamics also play a key role in the
binding of other Eph receptors to their ephrin ligands, we have
determined the crystal structure of the unbound EphA5 LBD and
characterized its dynamics on three time scales using NMR
spectroscopy and molecular dynamics simulations. EphA5 binds
only A-class ephrins [37] and is highly expressed in the developing
nervous system, where it plays important roles in repulsive axon
guidance and synaptogenesis [38–40]. EphA5 is also expressed in
many adult tissues, including the adult brain [38–42], and has
been proposed to play a role in synaptic plasticity and behavior as
well as drug addiction [42–44]. Outside the nervous system,
EphA5 has been found to play a role in insulin secretion in the
pancreas [45]. Increased EphA5 expression has also been
associated with pancreatic cancer proliferative capacity as well as
ovarian and hepatocellular cancer malignancies [46–49]. Howev-
er, other studies have shown that the EphA5 promoter is
hypermethylated in colorectal and breast cancer leading to
decreased receptor expression [50,51], and that EphA5 expression
is associated with tumor dormancy [52].
Our study reveals that the EphA5 LBD has dynamic properties
very different from those of the EphA4 LBD, despite the 74%
sequence identity (87% homology), their structural similarity and
their shared ability to bind ephrin-A ligands. This supports the
notion that the global conformational exchanges of the EphA4




The structure coordinates of the EphA5 LBD was deposited in
Protein Data Bank, with RCSB ID code of rcsb072038 and PDB
ID code of 4ET7.
Cloning, expression and purification of the EphA5
ligand-binding domain
The DNA fragment encoding the human EphA5 ligand-binding
domain (LBD), including residues 59–235 (GenBank accession
number: AAI43428.1) was amplified from a HeLa cell cDNA
library by using two primers containing BamHI and XhoI
restriction sites, 59-GGA TCC AAC GAA GTG AAT TTA
TTG GAT TCA CGC -39 (forward) and 59-CTC GAG TCA
AGA AGG CGC TTC TTT ATA GTA TAC -39 (reverse). The
PCR fragment was cloned into a modified pET32a vector
(Novagen), and subsequently the vector was transformed into
E. coli Rosetta-gami (DE3) cells (Novagen) as we previously
performed for the EphA4 LBD [14,17], which allows more
efficient formation of disulfide bonds and expression of eukaryotic
proteins containing codons rarely used in E. coli.
The recombinant EphA5 LBD was over-expressed by culturing
E. coli Rosetta-gami cells in Luria-Bertani medium at 37uC until
the absorbance at 600 nm reached ,0.6. Then 0.1 mM isopropyl
1-thio-D-galactopyranoside (IPTG) was added to induce the over-
expression at 18uC overnight. The harvested cells were sonicated
in lysis buffer containing 150 mM sodium chloride, 20 mM
sodium phosphate (pH 7.3) to release soluble His-tagged EphA5
LBD protein, which was subsequently purified by affinity chro-
matography using nickel-nitrilotriacetic acid-agarose (Qiagen).
In-gel cleavage of the fusion protein to release the EphA5 LBD
was performed at room temperature by incubating the fusion
protein attached to nickel-nitrilotriacetic acid-agarose with
thrombin overnight. The released EphA5 LBD was first purified
with an AKTA FPLC machine (Amersham Biosciences) on a gel
filtration column (HiLoad 16/60 Superdex 200) equilibrated with
a buffer containing 150 mM sodium chloride, 20 mM sodium
phosphate at pH 7.3, followed by a purification on an anion-
exchange column (Mono Q 5/50) with a gradient of 0–1 M NaCl
in 25 mM Tris-HCl buffer, pH 7.8.
Preparation of the WDC antagonistic peptide
To obtain the antagonistic peptide WDCNGPYCHWLG
(WDC), a PCR-based strategy was utilized to synthesize its gene
with E. coli preferred codons. Briefly, the gene was obtained by the
PCR reaction of two long oligonucleotides: Forward Primer (59-
GGA TCC TGG GAT TGC AAC GGC CCG TAT TGC CAT
TG -39) and Reverse Primer (59-CTC GAG TCA GCC CAG
CCA ATG GCA ATA CGG GCC-39) with a 17-mer overlap
Structure and Dynamics of the EphA5 LBD
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containing BamHI and XhoI restriction sites. The PCR fragment
was subsequently cloned into a modified pGEX-4T-1 vector
(Amersham Biosciences), which was transformed into E. coli
Rosetta-gami (DE3) cells for the expression (Novagen). The
peptide was released from the GST fusion protein by in-gel
thrombin cleavage followed by HPLC purifications on a RP-18
column (Vydac). The identity of the recombinant peptide was
verified by electrospray mass spectrometry and NMR resonance
assignments, which showed that the intramolecular disulfide was
already formed.
A modified WDC peptide (WDCNGPYCHWLG-(PEG)2-KK)
was synthesized by Anaspec, Inc. (San Jose, CA) and induced to
form an intramolecular disulfide bond between the two cysteine
residues. The purity of peptide with the intramolecular disulfide
bond was determined to be 99% by analytical HPLC.
Structure determination of the EphA5 LBD
The EphA5 LBD was prepared in a buffer containing 25 mM
Tris-HCl (pH 7.5), 150 mM NaCl and 5 mM CaCl2 at a
concentration of 10 mg/ml. A crystal screen was set up by
preparing 1 ml of the protein solution mixed with 1ml of the
reservoir solution as hanging drops at room temperature in a well
containing the reservoir solution. Rock-like crystals formed in the
well containing 0.1 M Tris-HCl (pH 8.5) and 2.0 M ammonium
sulfate after 5 days.
The crystal was protected by cryoprotectant (0.1 M Tris-HCl,
2.0 M ammonium sulfate, 25% glycol, pH 8.5). X-ray diffraction
images for a single crystal were collected using an in-house Bruker
X8 PROTEUM x-ray generator with a CCD detector. The data
were indexed and scaled by HKL2000 package [53] to be in the
space group C2221 (a = 55.04, b = 82.72, c = 81.17), with one
molecule per asymmetric unit, using the program SAINT. The
Matthews coefficient was 2.27 with 45.94% solvent constant by
CCP4 software package [54]. All figures were prepared using the
PyMOL molecular graphics system (Delano Scientific LLC, San
Carlos, CA).
ITC and NMR characterization of the binding of an
antagonistic peptide and an antagonistic small molecule
to the EphA5 LBD
ITC experiments were performed using a Microcal VP ITC
machine as we previously conducted on the EphA4 LBD [12,17].
Titrations of bacterially expressed WDC binding to the EphA5
LBD were conducted in 10 mM phosphate buffer, pH 6.3, at
25uC. The EphA5 LBD was placed in a 1.8 mL sample cell, while
the WDC peptide was loaded into a 300 mL syringe. The samples
were degassed for 15 min to remove bubbles before titrations were
initiated. A control titration experiment with the same parameters
setting was also performed without the EphA5 LBD to measure
the contribution of peptide dilution. To obtain thermodynamic
binding parameters, the titration data after subtracting the values
obtained from the control experiments were fitted to a single
binding site model using the built-in software ORIGIN version 5.0
(Microcal Software Inc.).
NMR samples were prepared in 10 mM phosphate buffer,
pH 6.3, with the addition of 10% D2O for NMR spin-lock. All
NMR data were collected at 25uC on an 800-MHz Bruker Avance
spectrometer equipped with a shielded cryoprobe as described
previously [12,14]. For the sequential assignment, a pair of triple-
resonance NMR spectra, HNCACB and CBCA(CO)NH, were
acquired on a double-labeled EphA5 sample at a concentration of
800 mM.
For NMR characterization of the binding of the EphA5 LBD
with the WDC peptide and the small molecule C1, two-
dimensional 1H-15N HSQC spectra were acquired at a protein
concentration of 100 mM in the absence and in the presence of the
WDC peptide or C1 at different molar ratios.
IC50 determination for the inhibition of ephrin-A5
binding to EphA5 by the WDC antagonistic peptide
Protein A-coated wells (Pierce Biotechnology, Rockford, IL)
were incubated with a 50 mL solution of 1 mg/mL rat EphA5 Fc in
Tris buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.5) containing
0.02 mM Tween-20 for 1 hour. Wells coated with rat EphA5 Fc
(R&D Systems) were then rinsed with Tris buffer, 0.01% Tween
20, and incubated with different synthetic WDC peptide
concentrations and 0.6 nM ephrin-A5 AP (0.94 OD min21
mL21) in a total volume of 50 mL for 1 hour. After washing away
the unbound peptide and ephrin, bound ephrin-A5 AP was
detected using 1 mM pNPP substrate. Data were fitted using non
linear regression and IC50 values were calculated using the
program Prism (GraphPad Software Inc.).
Eph receptor selectivity of the WDC antagonistic peptide
Protein A-coated wells (Pierce Biotechnology, Rockford, IL)
were incubated at room temperature with 50 mL solutions of
1 mg/mL EphA Fc receptors (EphA2-EphA8; R&D Systems) and
EphB Fc receptors (EphB1-EphB4 and EphB6) in Tris buffer for
1 hour. The wells were then rinsed with Tris buffer, 0.01% Tween
20 and incubated for 1 hour with either 0.6 nM ephrin-A5 AP
(0.94 OD min21 mL21) for the EphA receptors, or 0.2 nM ephrin-
B2 AP (0.32 OD min21 mL21) for the EphB receptors in the
presence or absence of 100 mM synthetic WDC peptide. After
washing away unbound ephrin and peptide, the amount of bound
ephrin was detected using 1 mM pNPP substrate.
Pulsed gradient field NMR determination
Pulsed gradient field (PGF) NMR experiments were utilized to
assess the oligomerization properties [55] of the EphA5 LBD in
10 mM phosphate buffer at pH 6.3, which were acquired at 25uC
on an 800 MHz Bruker Avance spectrometer. The NMR
experiments were implemented by use of the Bruker pulse
sequence ledbpgpprwg2 s and the Bruker macro diffusion ordered
spectroscopy (DOSY). Typically 16 values of gradient strength
were used in the range 0 to 32 G/cm, with PFG duration of 2 ms,
and diffusion time of 150 ms. The self-diffusion coefficients (Ds)
were calculated using the Bruker DOSY analysis program, with
intensities of peaks at 20.057 and 20.177 ppm. Each sample was
run in triplicate and Ds values were averaged over the three
experiments.
Protein dynamics on the second-hour time scale as
studied by NMR spectroscopy
Hydrogen-deuterium (H/D) exchange experiments were con-
ducted on the EphA5 LBD to gain an initial insight into its
dynamic behavior on the ms-hr time scale, as we previously
described for human ephrin-B2 and EphA4 [12]. Briefly, the 15N-
labeled EphA5 LBD in the 10 mM, pH 6.3 phosphate buffer was
lyophilized and then re-dissolved in D2O. The progress of the
exchange process between amide protons and deuterium was
followed by collecting a series of successive HSQC spectra starting
immediately after sample re-solubilization in D2O. All exchange
experiments were conducted on an 800 MHz Bruker Avance
spectrometer at 25uC. The first HSQC spectrum was collected
after 15 min, and the last spectrum was acquired after 24 hours.
Structure and Dynamics of the EphA5 LBD
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Protein dynamics on ps-ns time scale as studied by NMR
spectroscopy
15N backbone T1 and T1r relaxation times and {1H}-15N
steady state NOE intensities were collected on an 800 MHz
Bruker Avance spectrometer equipped with both an actively
shielded cryoprobe and pulse field gradient units [56]. Relaxation
time T1 was determined by collecting 8 points with delays of 10,
250, 650, 900, 1000, 1100, 1300 and 1400 ms using a recycle
delay of 1 s, with a repeat at 650 ms. Relaxation time T1r was
measured by collecting seven points with delays of 1, 22, 35, 48,
60, 70, 76 ms using a spin-lock power of 1.6 kHz and a 2.5 s
recycle delay with a repeat at 48 ms. {1H}-15N steady-state NOEs
were obtained by recording spectra with and without 1H
presaturation, a duration of 3 s and a relaxation delay of 6 s at
800 MHz. Relaxation times were fitted to peak height data as
single exponential decays.
Model-free analysis
NMR relaxation data were analyzed by ‘‘Model-Free’’ formal-
ism with protein dynamics software DYNAMICS [57]. Briefly,
relaxation of protonated heteronuclei is dominated by the dipolar
interaction with the directly attached 1H spin and by the chemical
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, m0is the per-
meability of free space; h is Planck’s constant; cX ,cHare the
gyromagnetic ratios of 1H and the X spin (X = 13C or 15N)
respectively; cXH is the X-H bond length; vHand vXare the
Larmor frequencies of 1H and X spins, respectively; andDsis the
chemical shift anisotropy of the X spin.
The Model-Free formalism, as previously established [58] and
further extended [59], determines the amplitudes and time scales
























In which, t~tstm=(tsztm), tmis the isotropic rotational correla-
tion time of the molecule, ts is the effective correlation time for
internal motions, S2~Sf
2Ss
2 is the square of the generalized
order parameter characterizing the amplitude of the internal
motions, and Sf
2and Ss
2are the squares of the order parameters
for the internal motions on the fast and slow time scales,
respectively.
In order to allow for diverse protein dynamics, several forms of
the spectral density function, based on various models of the local
motion [56–59], were utilized, which include the original Lipari-
Szabo approach, assuming fast local motion characterized by the
parameters S2 and tloc; extended model-free treatment, including
both fast (Sfast
2,tfast) and slow (Sslow
2,tslow) reorientations for the
NH bond (tfastvvtslowvtc); and could also allow for slow, milli-
to microsecond dynamics resulting in a conformational exchange
contribution, Rex, to the linewidth.
Protein dynamics on ms-ms time scale as studied by NMR
spectroscopy
15N transverse relaxation dispersion experiments for EphA5
LBD in the free state were acquired on a Bruker Avance 800
spectrometer equipped with a z-axis gradient cryoprobe at 298 K
[60]. A constant time delay (TCP = 50 ms) was used with a series
of CPMG frequencies, ranging from 40 Hz, 80 Hz, 120 Hz (x2),
160 Hz, 200 Hz, 240 Hz, 320 Hz, 400 Hz, 480 Hz, 560 Hz,
640 Hz, 720 Hz, 800 Hz, and 960 Hz (x2 indicates repetition). A
reference spectrum without the CPMG block was acquired to




Where I(nCPMG) is the peak intensity on the difference CPMG
frequency, I0 is the peak intensity in the reference spectrum.
Molecular dynamics simulations
To unravel the intrinsic dynamics of the EphA5 LBD, three
independent, 30 ns molecular dynamics simulations were per-
formed as we previously conducted [14,25,29]. Briefly, the
simulation cell is a periodic cubic box with a minimum distance
of 9 A˚ between the protein and the box walls to ensure the proteins
does not directly interact with its own periodic image. The water
molecules, described using the TIP3P model, were filled in the
periodic cubic box for the all atom simulations. Each set of
molecular dynamics simulations was implemented by using the
program GROMACS [61] for 30 ns, with the AMBER 99SB-
ILDN all-atom force field. The long-range electrostatic interac-
tions were treated using the fast particle-mesh Ewald summation
method. The temperature during simulations was kept constant at
300 K by Berendsen’s coupling. The pressure was held at 1 bar.
The isothermal compressibility was 4.6*1025 bar21. The time step
was set as 2 fs. All bond lengths including hydrogen atoms were
constrained by the LINCS algorithm. Prior to molecular dynamics
simulations, the initial EphA5 LBD structure was relaxed by 5,000
steps of energy minimization using a steepest descent algorithm,
followed by position restraint equilibration for 200 ps.
Results
Unique crystal structure of the EphA5 LBD
The human EphA5 LBD was cloned and expressed in soluble
form in E. coli. In solution this domain is a monomer, as assessed
by FPLC size exclusion chromatography (data not shown). We
also used pulsed gradient field NMR to measure the self-diffusion
coefficient of the EphA5 LBD, which is an indicator of aggregation
state in solution because it depends on the radius of a globular
protein. The self-diffusion coefficient is 1.1061021061.87610212
m2/s at a concentration of 500 mM, which is very similar to that of
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the monomeric EphA4 LBD (1.0861021062.36610212 m2/s)
[11–13], implying that the EphA5 LBD is also a monomer.
The crystal structure of the EphA5 LBD was determined at 2.6
A˚ resolution by the molecular replacement method using the
EphA4 LBD (3CKH) as a search module (Table S1). In the crystal
structure all residues are visible except for the last three (Figure 1a)
and one asymmetric unit contains only one EphA5 molecule,
which does not show any close contacts with other EphA5
molecules in the neighboring units. Overall, the EphA5 LBD
adopts the conserved jellyroll architecture characteristic of other
Eph receptors, composed of 11 antiparallel b-sheets arranged as a
compact b-sandwich. There are two conserved disulfide bridges,
one within the G–H loop (Cys137–Cys147) and the other between
the E–F and L–M loops (Cys102–Cys220).
The D–E and J–K loops, which cap the high affinity ephrin-
binding pocket, are well-defined in the crystal structure, with high
quality electronic densities (Figure 1b, c). This is striking because in
previously determined unbound Eph receptor LBD structures,
except that of EphA2, the D–E and J–K loops are either entirely
or partially invisible due to their high intrinsic dynamics
(Figure 2a). Remarkably, in the unbound EphA5 structure
Ala179-Ser182 and Gly189-Met193 in the J–K loop adopt a
helical-like conformation that resembles the structures previously
observed for ephrin-bound Eph receptors (Figure 2b). In contrast,
in the unbound EphB2 and EphA4 LBDs the corresponding J–K
loop residues form a short antiparallel b-sheet (Figure 2a).
Moreover, in the EphA5 LBD structure the distance between
D–E and J–K loops is larger than in other unbound Eph receptor
LBD structures. Hence, the high affinity ephrin binding pocket of
the EphA5 LBD resembles the open conformations previously
observed only in Eph receptor LBDs bound to ephrins (Figure 2b).
The EphA5 LBD is capable of unique ligand binding
specificity
WDC (WDCNGPYCHWLG) is a 12 amino acid-long peptide
that was previously identified in a phage-display screen based on
its binding to the entire extracellular domain of rat EphA5 [62].
Isothermal titration calorimetry (ITC) experiments yielded a Kd of
6.2 mM for binding to the EphA5 LBD (Figure 3a), demonstrating
that WDC also binds to human EphA5 and targets the LBD.
Consistent with this, in ELISA assays the peptide antagonizes
EphA5-ephrin-A5 interaction with an IC50 value of ,50 mM
(Figure 3b). The synthetic WDC peptide only significantly inhibits
ephrin binding to EphA5, but not other Eph receptors (Figure 3c).
These results suggest that WDC binds to the high affinity ephrin
binding pocket of EphA5, where it competes with ephrins for
binding. Moreover, the high selectivity of WDC implies that the
high affinity ephrin binding pocket of EphA5 has some unique
structural or/and dynamic properties that are not shared by other
Eph receptors.
Titrations of the 15N-labeled EphA5 LBD with WDC revealed
significant shifts of most HSQC peaks of the EphA5 LBD
(Figure 3d). This is consistent with previous results with the
EphA4-selective KYL peptide, which has a Kd of 0.8 mM, and
also induces extensive shifting of the HSQC peaks of the EphA4
LBD [63]. We further probed the uniqueness of the EphA5 ligand
binding pocket by using C1, an antagonistic small molecule that
shows selectivity for the EphA2 and EphA4 receptors and induces
shifts in several HSQC peaks of the EphA4 LBD [12,64]. Addition
of C1 at ratios of up to 1:20 (EphA5:C1) resulted in no detectable
shifts of the HSQC peaks (Figure 3e). This demonstrates that the
EphA5 LBD does not significantly bind C1, suggesting that the
unique structural features of the J–K loop may play a key role in
defining its ligand binding specificity.
Figure 1. The crystal structure of the EphA5 LBD shows well defined D–E and J–K loops. (a) Crystal structure of the EphA5 LBD. Residues
Ala179-Ser182 and Gly189-M193 in the J–K loop, which adopt unusual helical-like conformations, are displayed in red. Two disulfide bridges Cys137-
Cys147 and Cys102-Cys220, are displayed in orange. (b, c) Electron density maps for the D–E and J–K loops, showing that all residues are well defined.
doi:10.1371/journal.pone.0074040.g001
Figure 2. The structure of the unbound EphA5 LBD resembles
that of other Eph receptors bound to ephrin ligands. (a)
Superimposition of the LBD structures of unbound EphA5 (red), EphA2
(green, 3C8X), EphA4 (yellow, 3CKH) and EphB2 (blue, 3ETP). A short b-
sheet is formed by the EphA4 and EphB2 residues corresponding to
EphA5 residues Ala179-Ser182 and Gly189-M193 in the J–K loop
(orange arrows). (b) Superimposition of the LBD structures of the
unbound EphA5 (red), EphA2 in complex with ephrin-A2 (green, 3CZU),
EphA4 with ephrin-A2 (cyan, 3WO3), EphA4 with ephrin-B2 (blue,
3GXU), EphB2 with ephrin-B2 (pink, 1KGY) and EphB4 with ephrin-B2
(yellow, 2HLE).
doi:10.1371/journal.pone.0074040.g002
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The D and E strands of the EphA5 LBD are exposed to the
solvent
To assess the structural and dynamic properties of the EphA5
LBD in solution, we obtained its NMR sequential assignments by
analyzing the HNCACB and CBCA(CO)NH pair of triple-
resonance NMR spectra. Figure 4a shows residue-specific Ca
chemical shift deviations from the random coil values for the
EphA5 LBD, which are very sensitive indicators of protein
Figure 3. Unique ligand-binding specificity of the EphA5 LBD. (a) Isothermal titration calorimetry profiles for the interaction of the EphA5
LBD with the WDC peptide (upper panel) and plots of the integrated values for the reaction heats (after blank subtraction and normalization to the
amount of the peptide injected) versus EphA5 to WDC molar ratio (lower panel). The thermodynamic binding parameters are shown in the lower
panel. (b) Inhibition of ephrin-A5 alkaline phosphatase (AP) binding to immobilized EphA5 Fc by increasing concentrations of WDC in ELISAs. Bound
ephrin-A5 AP represents the ratio of the OD at 405 nm for ephrin-A5 AP bound to EphA5 Fc in the presence of the indicated concentrations of the
WDC peptide and in the absence of peptide. (c) Inhibition of ephrin-A5 AP binding to EphA receptors and ephrin-B2 AP binding to EphB receptors by
100 mM WDC. Bound ephrin AP represents the ratio of the OD at 405 nm for ephrin-A5 AP or ephrin-B2 AP bound to different Eph receptor Fc
proteins in the presence of WDC peptide and in the absence of peptide. The peptide substantially inhibits ephrin binding only to EphA5. Averages
and standard errors from triplicate measurements are shown. (d) Superimposition of the NMR HSQC spectra of the EphA5 LBD in the absence (blue)
and in the presence (red) of WDC at a molar ratio of 1:3 (EphA5:WDC). (e) Superimposition of the NMR HSQC spectra of the EphA5 LBD in the absence
(blue) and in the presence (red) of C1 at a molar ratio of 1:20 (EphA5:C1).
doi:10.1371/journal.pone.0074040.g003
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secondary structure. The positive Ca conformational shifts for the
J–K loop residues Asp180-Glu181 and Gly189-Asp190 indicate
that these two regions adopt a helical-like conformation in solution
rather than an extended b-stranded conformation, consistent with
the structure of this loop observed in the crystal.
We then utilized NMR hydrogen/deuterium exchange to assess
the backbone dynamics of the EphA5 LBD on the min-hr time
scale. It is well established that in solution the labile hydrogens of
proteins, such as the amide protons, are continually exchanging
with the solvent at different rates. The rates of hydrogen exchange
depend on a variety of factors associated with the environment,
including exposure of the hydrogens to the solvent and their
involvement in hydrogen bonds. Consequently, amide hydrogen/
deuterium exchange experiments provide a sensitive readout for
the degree of exposure of amide protons to the solvent [14].
Approximately ,58% of the 172 non-proline residues in the
EphA5 LBD completely exchanged with deuterium within the
experimental dead time of 15 min, indicating that the loop regions
are all accessible to the solvent (Figure 4b, d). Interestingly, in
addition to the loop residues, which would be predicted to be
solvent-exposed, many residues in the D and E b-strands also
completely exchanged within 15 min (Figure 4d). This result is
dramatically different from our previous finding that most amide
protons of residues in the D and E strands of the EphA4 LBD
remained unexchanged even after 24 hours [14]. After 2 hours,
amide protons of additional EphA5 residues undergo exchange
and ,27% of the residues still have deuterium and can therefore
yield HSQC peaks (Figure 4c). These slow-exchanging amide pro-
tons are mostly located in the b-strands (Figure 4d). Finally, a few
additional HSQC peaks disappear after 24 hours (Figure 4c, d).
Backbone dynamics of the EphA5 LBD as determined
by NMR
15N NMR backbone relaxation data, including the longitudinal
relaxation time T1, transverse relaxation time T2, and {1H}-15N
Figure 4. Structural properties and solvent accessibility of the EphA5 LBD in solution. (a) Residue-specific Ca chemical shift deviations
(DCa = dobs – dcoil) for the EphA5 LBD. The bars for the J–K loop residues with helical conformations in the crystal structure are colored in red. (b)
Superimposition of 1H-15N NMR HSQC spectra for the 15N-labeled EphA5 LBD at 25uC in 10 mM phosphate buffer, pH 6.5 (blue) and 15 min after
dissolving the lyophilized sample in D2O (red). The disappearance of the blue HSQC peaks indicates the high exposure of the amide protons to the
solvent. (c) Superimposition of HSQC spectra of the EphA5 LBD at 25uC, 15 min (blue) and 24 hours (red) after dissolving the lyophilized sample in
D2O. (d) EphA5 LBD structure with residues whose HSQC peaks are missing even in H2O buffer colored in green, residues whose backbone amide
protons completely exchanged within 15 min in blue, residues whose backbone amide protons persisted after 15 min but completely exchanged in
2 hours in yellow, and residues whose backbone amide protons persisted even after 2 hours in red. The very rapid exchange of their amide protons
indicates that the D and E strands are highly exposed to the solvent.
doi:10.1371/journal.pone.0074040.g004
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steady-state NOE are sensitive indicators of protein dynamics on
the ps-ns timescale. Figure S1a–c shows the relaxation data for the
EphA5 LBD, with the {1H}-15N steady-state NOEs of most
residues forming secondary structures larger than 0.75, which
indicates that the regions with secondary structures have
significantly limited backbone motion. To gain a quantitative
insight, the NMR relaxation data for the EphA5 LBD were further
analyzed by ‘‘Model-free’’ formalism [56–59]. However, due to
the overlap and/or weak intensity of many resonance peaks
resulting from the relatively large size of the protein and the
presence of many exposed loop residues, only 128 out of 172 non-
proline peaks were suitable for this analysis. Isotropic, axially
symmetric and fully anisotropic models for the overall motions
were examined and compared. A fully anisotropic model was
selected, yielding the parameters for the overall rotational diffusion
of the free EphA5 LBD shown in Table S2. This analysis
generated squared generalized order parameters, S2, which reflect
the conformational rigidity on a ps-ns time scale. S2 values range
from 0 for high internal motion to 1 for completely restricted
motion in a molecular reference frame. As shown in Figure 5a, the
regions with secondary structure have higher S2 values, indicating
high backbone rigidity, while the loop regions have smaller S2
values, suggesting high flexibility. In particular, the residues in the
D–E, G–H and J–K loops have relatively low S2 values, implying
that these residues undergo significant conformational exchanges
on the ps-ns time scale.
Model-free analysis also yields Rex values, which reflect
conformational exchanges on ms-ms time scale. As shown in
Figure 5b, only 10 residues in the EphA5 LBD have Rex values
.2 Hz, including residues Gly87-Val89 in the D strand, Lys103 in
the E–F loop, Leu134 in the G–H loop, Asn169 and Gln170 in the
I–J loop, Glu181 and Met193 in the J–K loop, and Lys207 in the
K–L loop (Figure 5b, d). In contrast, Rex values .2 Hz were
previously detected over the whole unbound EphA4 LBD [36].
We also conducted CPMG-based relaxation dispersion experi-
ments, but detected only three residues with DR2 (tcp) .1.5 Hz
(Figure S2). Together with the Rex results from the Model-free
analysis, this indicates that in the unbound state the EphA5 LBD
does not appear to have global conformational exchanges on the
ms-ms time scale.
Dynamics of the EphA5 LBD as determined by molecular
dynamics simulations
To further explore the dynamic behavior of the EphA5 LBD,
we initiated three independent 30 ns molecular dynamics simu-
lations. In all simulations, the root-mean-square deviations
(RMSD) values for the heavy atoms increased very rapidly during
the first 0.8 ns (Figure 6a). This is mostly due to the relaxations of
the crystal structures becoming solvated in solution. Although the
three RMSD trajectories have some local differences, their average
values over 30 ns are very similar (2.1660.34, 2.0660.32 and
2.1560.25 A˚).
Figure 6b shows the root-mean-square fluctuations (RMSF) of
the Ca atoms in the EphA5 LBD for the three parallel 30 ns
simulations. The average RMSF values over 30 ns are also similar
(1.0260.78, 0.9760.62 and 0.9260.56 A˚). However, there are
some differences in local regions, in particular over D–E loop
residues Asp90-Ala94 (Figure 6b), mostly due to the fact that the
system behaves as non-ergodic in 30 ns simulations. Interestingly,
other than the N-terminus, the residues with RMSF values larger
than average are all located over loops, including the A–C, D–E,
G–H, I–J, and J–K loops (Figure 6c). Nevertheless, only residues
Asp90-Ala94 in the D–E loop and Asp187-Gly189 in the J–K loop
have RMSF values larger than 2-fold the average value. These
results are consistent with the dynamic behaviors deduced from
hydrogen/deuterium exchange (Figure 4) and Model-free analysis
(Figure 5).
The extremely high RMSF values for D–E loop residues Asp90-
Ala94 represent a unique property of the EphA5 LBD because in
molecular dynamics simulations of the EphA4 LBD, the RMSF
values of the D–E loop residues were not significantly larger than
those of residues in other loops, and in fact were even slightly
smaller than those of J–K loop residues [14]. In the unbound
EphA4 LBD the D–E loop shows a tendency to move towards the
J–K loop (Figure 7), as indicated by the decreasing distances
between the Ca atoms of Glu91 in the D–E loop and Val192 in
the J–K loop (Figure 7b, d). However even after 20 ns, when this
distance becomes largely stable, the average values of this distance
still remain very large for EphA5: 8.7760.84, 12.5661.76, and
10.7662.04 A˚ for the three simulations. It is noteworthy that J–K
loop residues Gly189-Met193 have completely different dynamic
behaviors in EphA5 and EphA4. In EphA5, these residues initially
form a helical-like conformation, which becomes a stable helix in
the simulations (Figure 7a–c). In contrast, the corresponding
residues form a short b-strand in EphA4, which became further
extended in previous molecular dynamics simulations [14].
Discussion
To understand the structural and dynamic principles that
enable different Eph receptors to achieve distinct ligand binding
specificities by utilizing the same LBD architecture, in this study
we determined the first crystal structure of the LBD of EphA5, a
receptor that has higher ligand binding selectivity than the EphA4
LBD. In the EphA5 crystal structure, all D–E and J–K loop
residues are visible and adopt helical-like conformations over
Ala179-Ser182 and Gly189-Met193. This unique feature was
confirmed by NMR characterization. Strikingly, the ligand
binding pocket of the unbound EphA5 LBD resembles the open
form previously observed only in other Eph receptor LBDs when
they are bound to ephrins. That the EphA5 ephrin-binding pocket
has an open conformation in the absence of a bound ephrin is
strongly supported by the NMR hydrogen-deuterium exchange
results showing that most EphA5 D and E strand residues are
highly accessible to the solvent. This is markedly different from our
previous results showing that most D and E strand residues of the
EphA4 LBD are protected from the solvent [14].
Surprisingly, although the J–K loop residues Ala179-Ser182
and Gly189-Met193 are identical in EphA5 and EphA4 with the
exception of Ile192 in EphA5, which corresponds to the
homologous Val in EphA4 (Figure 8a), they assume helical-like
conformations in EphA5 (Figure 8b) but form short antiparallel b-
sheets in EphA4 (Figure 8c). So what is responsible for this
difference? As shown in Figure 8c, the tips of the D–E and J–K
loops are in close contact in the EphA4 LBD, with a direct contact
of an Ile and an Asp residues. Interestingly, while the EphA4 Asp
residue corresponds to Asp190 in EphA5, the EphA4 Ile
corresponds to Glu80 in EphA5. Since other D–E and J–K loop
residues are either identical in EphA5 and EphA4, or not near the
region of interaction between the two loops in the unbound
EphA4 structure, it is likely that the repulsive electrostatic force
between Glu80 and Asp190 is the main mechanism preventing the
D–E and J–K loops of EphA5 from becoming as close as those in
the unbound EphA4 LBD structure. This is supported by the
molecular dynamics simulation results showing that after 20 ns,
when the distance between the D–E and J–K loops of EphA5 has
become largely stable, the distance still remains very large as
compared with that in the EphA4 LBD [14]. It appears that in
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EphA5, Ala179-Ser182 and Gly189-Met193 undergo a chame-
leon transformation into helical-like conformations mostly due to
the absence of long-range interactions between D–E and J–K
loops. It is well established that helices can be stabilized by local
interactions while b-sheets are mostly specified by long-range
interactions and their presence is, therefore, highly context-
dependent. Consequently, loss of long-range interactions usually
leads to the chameleon transformation into helical conformations
as exemplified by our previous reports [29,65,66].
As the EphA5 ephrin-binding pocket is highly populated with
the open conformations, the binding of ephrin-A ligands is
expected to trigger a shift in their equilibrium that involves only
small variations mostly over the loops instead of the large
differences observed for the EphA4 LBD [14]. Since conforma-
tions characterized by small differences in the loops are separated
Figure 5. 15N backbone dynamics for the EphA5 LBD on the ps-ns time scale. (a) Generalized squared order parameter (S2) derived from the
Model-free analysis of the relaxation data for EphA5. Red indicates residues with S2, the average value. (b) Residue-specific Rex derived from Model-
free analysis of relaxation data for EphA5 (green) and EphA4 (red and light brown). Red indicates EphA4 residues in the D and E strands as well as D–E
and J–K loops while light brown for the other EphA4 residues. (c) EphA5 LBD structure with residues having S2 , the average value (0.7) colored in
green and those with S2 , the average – STD (0.5) in red. (d) EphA5 LBD structure with residues having Rex .2 Hz colored in cyan and those .5 Hz
colored in red.
doi:10.1371/journal.pone.0074040.g005
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Figure 6. Distinctive dynamic behaviors of the EphA5 LBD as revealed by molecular dynamics simulations. (a) Trajectories of root-
mean-square deviations (RMSD) of heavy atoms in three independent molecular dynamics simulations. (b) Trajectories of root-mean-square
fluctuations (RMSF) of the Ca atoms computed for three independent simulations, with average values and standard deviations calculated over 30 ns
for each simulation. (c) EphA5 LBD structure with the residues having RMSF .average in green and those .2-fold the average in red.
doi:10.1371/journal.pone.0074040.g006
Figure 7. Molecular dynamics simulations reveal that the unbound EphA5 ephrin-binding pocket is in an open conformation. (a–c)
Superimposition of structure snapshots taken at 1 ns intervals in three independent molecular dynamics simulations. (d) Trajectories of the distances
between the Ca atoms of Glu91 in the D–E loop and Val192 in the J–K loop over 30 ns simulations. The average values and standard deviations
calculated over the 30 ns are displayed for each simulation. The EphA5 ligand binding pocket still remains open even after 30 ns in all three
simulations.
doi:10.1371/journal.pone.0074040.g007
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by relatively small energy barriers, their exchanges are predicted
to occur mostly over the ps-ns time scale. Indeed, our NMR and
molecular dynamics results reveal that the EphA5 LBD has
intrinsic dynamics in the ps-ns time scale over loop regions, as also
previously observed for the EphA4 LBD [14]. However, NMR
experiments did not reveal global conformational exchanges on
the ms-ms time scale for the EphA5 LBD. This is in contrast to the
EphA4 LBD, which has considerable conformational exchanges
on the ms-ms time scale over the whole domain [14,36]. It appears
that the open conformations populated by the EphA5 LBD are
only suitable for binding ephrin-As, according to the ligand
specificity of EphA5.
Our study thus suggests that protein dynamics play a key role in
modulating the binding specificity of Eph receptors for various
ligands through a conformational selection mechanism [14,35], as
previously observed on other proteins [26–28,30–35,67–69].
However, ‘conformational selection’ is a population-based frame-
work and not incompatible with ‘induced fit’ or even ‘lock-and-
key’ mechanisms. Indeed, the structural and dynamic properties of
the EphA5 LBD enable its unique ligand binding specificity. For
example, EphA5 is the only Eph receptor capable of binding
WDC with substantial affinity (Kd = 6 mM). In contrast, C1, an
antagonistic small molecule that binds the EphA4 LBD with a Kd
of 20 mM [12,22], shows no detectable binding to EphA5. We
previously showed that C1 forms a complex with the EphA4 LBD
by interacting with residues on both D–E and J–K loops [12].
Most likely, the inability of C1 to bind to EphA5 is consistent with
the idea that the unbound EphA5 LBD is populated with an open
conformation in which D–E and J–K loops are not close enough to
allow C1 to interact with residues from both loops. However,
although our previous study showed that the negatively-charged
carboxylic and hydroxyl groups on the benzene ring are involved
in hydrogen bonding to the side-chain amide protons of Gln43 in
EphA4 [12], it is not possible to exclude that the presence of Glu80
in EphA5 may also contribute to some degree to the lack of C1
binding. These findings imply that a general strategy for the design
of selective agonists or antagonists would be to target specific
dynamic states of the Eph receptor LBDs, even though they all
share a common jellyroll b-sandwich fold.
In conclusion, by the complementary use of crystallography,
NMR spectroscopy and computational simulations, we have
unraveled the distinctive structural and dynamic properties
associated with the EphA5 LBD. Interestingly, our results suggest
that although the EphA5 LBD has high sequence homology with
the EphA4 LBD and the same overall architecture, it is still able to
manifest different binding specificity through conformational
selection mechanism as previously proposed [14,35]. Moreover,
our results also imply a mechanism by which differential dynamics
of the same three-dimensional fold adopted by highly homologous
sequences result in different binding specificities.
Supporting Information
Figure S1 15N backbone relaxation data for the EphA5
LBD. (a) R1 values, which are the inverse of T1 (longitudinal)
relaxation times. (b) R2 values, which are the inverse of T2
(transverse) relaxation times. (c) {1H}-15N steady state NOE
intensity (hNOE), which offers a reliable measure of backbone
dynamics on the ps-ns time scale. (d) EphA5 LBD structure with
the residues having hNOE values , the average (0.65) colored in
red.
(TIF)
Figure S2 CPMG dispersion measurements reveal that
the EphA5 LBD lacks global conformational exchanges
in the ms-ms time scale. (a) Difference of effective transverse
relaxation rate R2 (tcp) at 80 and 960 Hz. Only three residues
have DR2 (tcp) .1.5 Hz, which indicates that only these residues
have conformational exchanges on the mm-ms time scale. (b)
EphA5 LBD with the three residues having DR2 (tcp) .1.5 Hz
displayed as spheres.
(TIF)
Table S1 Crystallographic data and refinement statis-
tics for the EphA5 LBD structure.
(DOCX)
Table S2 Characteristics of the overall rotational
diffusion of the EphA5 LBD.
(DOCX)
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Figure 8. Sequence-structure relationship for the EphA5 and
EphA4 LBDs. (a) Alignment of the sequences of the EphA5 and EphA4
LBDs. Identical residues are colored in blue, homologous in green and
different in black. Residues in the D and E b-strands are highlighted in
yellow and residues in the J–K loop in pink. Two residues that are in
close contact in the EphA4 structure (Ile in the D strand and Asp in the
J–K-loop) and the corresponding residues in the EphA5 LBD are boxed.
(b) Structure of the EphA5 LBD with spheres for Asp190 in the J–K-loop,
and Glu80 in the D strand which corresponds to a Ile in the structure of
the EphA4 LBD (c).
doi:10.1371/journal.pone.0074040.g008
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